antimicrobial resistance
FDA rejection of Spero’s tebipenem ‘raises resistance threat’
Phil Taylor
antibiotic, antimicrobial resistance, fda, regulatory, Spero Therapeutics, tebipenem
0 Comment
R&D/ Views & Analysis/ Views and analysis
The antimicrobial pipeline is ‘dry’ and that’s a problem
Ben Hargreaves
antimicrobial resistance, World Health Organisation
0 Comment
US study finds high rates of unneeded antibiotic prescribing
Phil Taylor
antibiotic, antimicrobial resistance, patients, prescribing, US
0 Comment
News/ News/ Sales and Marketing
UK launches its ‘Netflix-style’ payment model for antibiotics
Phil Taylor
antibiotic, antimicrobial resistance, Fetcroja, NHS, NICE, Pfizer, Shionogi, UK, value-based models, Zavicefta
0 Comment
Sandoz, Ares extend digital alliance on antimicrobial resistance
Phil Taylor
antibiotic, antimicrobial resistance, Ares Genetics, generic, infectious disease, OpGen, Sandoz
0 Comment
Pharma-backed antibiotic fund makes first investments
Phil Taylor
AMR Action Fund, antibiotic, antimicrobial resistance, financing, infectious disease
0 Comment
Venatorx plans new antibiotic filing after phase 3 readout
Phil Taylor
antibiotic, antimicrobial resistance, Venatorx Pharmaceuticals
0 Comment
Boehringer backs AI-powered anti-infective startup ArrePath
Phil Taylor
anti-infectives, antimicrobial resistance, ArrePath, artificial intelligence, digital, digital health, financing, machine learning
0 Comment